Disorder of mineral absorption and transport
MONDO:001776150 clinical trials for this condition and its sub-types, 0 tagged with Disorder of mineral absorption and transport itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disorder of mineral absorption and transport
-
Disorder of copper metabolism 0 trials · 35 incl. sub-types
6 sub-types
- Wilson disease 31 trials
- Menkes disease 5 trials
- Occipital horn syndrome 1 trial
- MEDNIK syndrome 0 trials
- Autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect 0 trials
- Familial benign copper deficiency 0 trials
-
Disorder of iron metabolism and transport 0 trials · 9 incl. sub-types
5 sub-types
- Hereditary hemochromatosis 8 trials Sub-types →
- Atransferrinemia 1 trial
- Aceruloplasminemia 0 trials
- Microcytic anemia with liver iron overload 0 trials
- Neuroferritinopathy 0 trials
-
Disorder of magnesium transport 0 trials · 5 incl. sub-types
1 sub-type
-
Disorder of zinc metabolism 0 trials · 2 incl. sub-types
3 sub-types
-
Disorder of manganese transport 0 trials
2 sub-types
Most studied deeper sub-types
-
New Once-Daily drug could simplify Wilson's disease treatment
Disease control Not yet recruitingThis Phase 3 trial compares a new once-daily formulation of trientine tetrahydrochloride (TETA 4HCl) to the standard drug D-penicillamine for people newly diagnosed with Wilson's disease. About 38 adults and children (ages 8 and up, weighing at least 55 lbs) will be randomly assi…
Phase 3 • Sponsor: Orphalan • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Gene therapy could free Wilson's patients from daily pills
Disease control Not yet recruitingThis early-stage trial tests a single-dose gene therapy called LY-M003 in 18 adults with Wilson's disease, a genetic condition that causes copper buildup. The goal is to see if it's safe and can reduce or eliminate the need for standard daily medications. Participants receive one…
Phase 1/2 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy trial aims to fix copper buildup in Wilson's disease
Disease control Not yet recruitingThis early-stage trial tests a gene therapy called GC310 for Wilson's disease, a genetic condition that causes copper buildup in the body. Researchers will give a single dose to 15 adults and monitor them for a year to check safety and whether it improves copper levels. The goal …
Phase 1/2 • Sponsor: GeneCradle Inc • Aim: Disease control
Last updated Jun 26, 2026 17:24 UTC
-
Hidden kidney damage in Wilson's disease under the microscope
Knowledge-focused Not yet recruitingThis study looks at how often kidney problems occur in people with Wilson's disease, a rare genetic condition that causes copper buildup. Researchers will check 150 patients aged 7 and older for signs of kidney damage, including chronic kidney disease, tubule issues, and calcium …
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New study maps the hidden struggles of Wilson's disease patients in rural egypt
Knowledge-focused Not yet recruitingThis study looks at the real-life challenges faced by people with Wilson's disease in Upper Egypt, a rare condition where copper builds up in the body. Researchers will survey 66 patients and their caregivers about diet, knowledge, attitudes, and barriers to care. The goal is to …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New study to uncover hidden hormone problems in kids with Wilson's disease
Knowledge-focused Not yet recruitingThis study will check for hormone problems in 30 children with Wilson's disease, aged 3 to 18. Researchers will look at how the pituitary, thyroid, adrenal, and sex glands are working. The goal is to find out how common these issues are and what types occur, which could help impr…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC